Toll Free: 1-888-928-9744
Published: Mar, 2015 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Aestus Therapeutics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Aestus Therapeutics, Inc. - Product Pipeline Review - 2015', provides an overview of the Aestus Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Aestus Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Aestus Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Aestus Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Aestus Therapeutics, Inc.'s pipeline products Reasons To Buy - Evaluate Aestus Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Aestus Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Aestus Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Aestus Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aestus Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Aestus Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Aestus Therapeutics, Inc. Snapshot 5 Aestus Therapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 Aestus Therapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Aestus Therapeutics, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Aestus Therapeutics, Inc. - Pipeline Products Glance 10 Aestus Therapeutics, Inc. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Phase I Products/Combination Treatment Modalities 11 Aestus Therapeutics, Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Aestus Therapeutics, Inc. - Drug Profiles 13 Atx08-001 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Atx09-002 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 ATx11-004 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Drug for Epilepsy 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Small Molecule for Amyotrophic Lateral Sclerosis 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Aestus Therapeutics, Inc. - Pipeline Analysis 20 Aestus Therapeutics, Inc. - Pipeline Products by Target 20 Aestus Therapeutics, Inc. - Pipeline Products by Route of Administration 21 Aestus Therapeutics, Inc. - Pipeline Products by Molecule Type 22 Aestus Therapeutics, Inc. - Pipeline Products by Mechanism of Action 23 Aestus Therapeutics, Inc. - Recent Pipeline Updates 24 Aestus Therapeutics, Inc. - Dormant Projects 25 Aestus Therapeutics, Inc. - Discontinued Pipeline Products 26 Discontinued Pipeline Product Profiles 26 Atx08-001 26 Atx09-002 26 Aestus Therapeutics, Inc. - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29
List of Tables Aestus Therapeutics, Inc., Key Information 5 Aestus Therapeutics, Inc., Key Facts 5 Aestus Therapeutics, Inc. - Pipeline by Indication, 2015 7 Aestus Therapeutics, Inc. - Pipeline by Stage of Development, 2015 8 Aestus Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015 9 Aestus Therapeutics, Inc. - Phase II, 2015 10 Aestus Therapeutics, Inc. - Phase I, 2015 11 Aestus Therapeutics, Inc. - Preclinical, 2015 12 Aestus Therapeutics, Inc. - Pipeline by Target, 2015 20 Aestus Therapeutics, Inc. - Pipeline by Route of Administration, 2015 21 Aestus Therapeutics, Inc. - Pipeline by Molecule Type, 2015 22 Aestus Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015 23 Aestus Therapeutics, Inc. - Recent Pipeline Updates, 2015 24 Aestus Therapeutics, Inc. - Dormant Developmental Projects,2015 25 Aestus Therapeutics, Inc. - Discontinued Pipeline Products, 2015 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.